You searched for "obstruction"
Grasping opportunities and taking chances: an accidental journey to the perfect destination
Here, Jonathan Parsons tells us more about his journey from clinical audiologist to setting up a social enterprise in the National Health Service. My route to Exeter and to a social enterprise has had several twists and turns and not...
A single blinded RCT comparing triamcinolone with 5-FU treatment for keloid scars
This single blinded RCT compared 43 patients with 50 symptomatic keloids that were randomised to two matched groups of 25 scars, receiving either 5-fluorouracil (5-FU) or current first line treatment, triamcinolone (TAC). The surgeon administering the injectable treatments was unblinded,...Dr KJ Lee: From Penang to Presidency of the AAO-HNS… and beyond!
Anyone who’s ever stopped to wonder about the personalities behind well-known names in ENT will enjoy Keyu Liu’s article on Dr KJ Lee, rich with stories of his travels, inspirations, and personal philosophies, alongside his momentous achievements. If you’ve experienced...The role of public health in addressing age-related hearing loss
Prevention and treatment of hearing loss needs to be viewed through a public health lens, but what does that look like? Kelly Reavis and colleagues explain the steps to addressing hearing healthcare from a public health perspective and why this...
What to do with incidental findings on FDG PET/CT?
18F-fluoro-deoxy-glucose positron emission tomography/computed tomography (FDG PET/CT) is commonly used in head and neck cancer staging. This investigation frequently identifies incidental findings unrelated to the index head and neck cancer. To assess the nature of these incidental findings, notes of...
Prognostic value of neutrophil-to-lymphocyte ratio in HPV-positive oropharyngeal cancer
The authors propose that high neutrophil-to-lymphocyte ratio (NLR) is associated with poor disease-free survival (DFS) in patients with human papillomavirus positive (HPV+) oropharyngeal cancer (OPC). This is a retrospective study that compared the outcomes of 43 patients treated for HPV+...
